Hyperlipidemia-associated renal damage decreases Klotho expression in kidneys from ApoE knockout mice

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Sastre, Cristina ^a   Rubio Navarro, Alfonso ^a   Buendiá, Irene ^a   Goḿez Guerrero, Carmen ^a   Blanco, Julia ^b   Mas, Sebastian ^a   Egido, Jesús ^a,c   Blanco Colio, Luis Miguel ^a   Ortiz, Alberto ^a   Moreno, Juan Antonio ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHEMOKINE; CHOLESTEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KLOTHO PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOWN REGULATION; GENE EXPRESSION; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; KIDNEY EPITHELIUM; KIDNEY INJURY; KIDNEY TUBULE CELL; KNOCKOUT MOUSE; MACROPHAGE MIGRATION; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

ANIMALS; APOLIPOPROTEINS E; CELL LINE; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLUCURONIDASE; HYPERLIPIDEMIAS; INFLAMMATION; INFLAMMATION MEDIATORS; KIDNEY; KIDNEY DISEASES; LIPID METABOLISM; LIPOPROTEINS, LDL; MALE; MICE; MICE, KNOCKOUT; OXIDATIVE STRESS;

EID: 84893635356     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083713     Document Type: Article

References (53)

1. Collins AJ, Li S, Gilbertson DT, Liu J, Chen SC, et al. (2003) Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int Suppl 87: S24-31. (Pubitemid 37315504)
2. Attman PO, Alaupovic P, Samuelsson O (1999) Lipoprotein abnormalities as a risk factor for progressive nondiabetic renal disease. Kidney Int Suppl 71: S14-7. (Pubitemid 29304804)
3. Oda H, Keane WF (1997) Lipids in progression of renal disease. Kidney Int Suppl 62: S36-8. (Pubitemid 27489399)
4. Bosmans JL, Holvoet P, Dauwe SE, Ysebaert DK, Chapelle T, et al. (2001) Oxidative modification of low-density lipoproteins and the outcome of renal allografts at 1 1/2 years. Kidney Int 59: 2346-56. (Pubitemid 32467629)
5. Agarwal A, Balla J, Balla G, Croatt AJ, Vercellotti GM, et al. (1996) Renal tubular epithelial cells mimic endothelial cells upon exposure to oxidized LDL. Am J Physiol 271: F814-23.
6. Munoz-Garcia B, Moreno JA, Lopez-Franco O, Sanz AB, Martín-Ventura JL, et al. (2009) Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout mice. Arterioscler Thromb Vasc Biol 29: 2061-8.
7. Bentley MD, Rodriguez-Porcel M, Lerman A, Sarafov MH, Romero JC, et al. (2002) Enhanced renal cortical vascularization in experimental hypercholesterolemia. Kidney Int 61: 1056-63. (Pubitemid 34175475)
8. Chade AR, Rodriguez-Porcel M, Grande JP, Krier JD, Lerman A, et al. (2002) Distinct renal injury in early atherosclerosis and renovascular disease. Circulation 106: 1165-71. (Pubitemid 34970861)
9. Drueke TB, Nguyen Khoa T, Massy ZA, Witko-Sarsat V, Lacour B, et al. (2001) Role of oxidized low-density lipoprotein in the atherosclerosis of uremia. Kidney Int Suppl 78: S114-9. (Pubitemid 32144082)
10. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, et al. (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390: 45-51. (Pubitemid 27494749)
11. Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, et al. (2005) Suppression of aging in mice by the hormone Klotho. Science 309: 1829-33. (Pubitemid 41325087)
12. Saito Y, Nakamura T, Ohyama Y, Suzuki T, Iida A, et al. (2000) In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome. Biochem Biophys Res Commun 276: 767-72.
13. Prie D, Beck L, Urena P, Friedlander G (2005) Recent findings in phosphate homeostasis. Curr Opin Nephrol Hypertens 14: 318-24. (Pubitemid 40863067)
14. Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, et al. (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444: 770-4. (Pubitemid 44949607)
15. Yamamoto M, Clark JD, Pastor JV, Gurnani P, Nandi A, et al. (2005) Regulation of oxidative stress by the anti-aging hormone klotho. J Biol Chem 280: 38029-34. (Pubitemid 41642417)
16. Wang Y, Sun Z (2009) Current understanding of klotho. Ageing Res Rev 8: 43-51.
17. Maekawa Y, Ishikawa K, Yasuda O, Oguro R, Hanasaki H, et al. (2009) Klotho suppresses TNF-alpha-induced expression of adhesion molecules in the endothelium and attenuates NF-kappaB activation. Endocrine 35: 341-6.
18. Aizawa H, Saito Y, Nakamura T, Inoue M, Imanari T, et al. (1998) Downregulation of the Klotho gene in the kidney under sustained circulatory stress in rats. Biochem Biophys Res Commun 249: 865-71. (Pubitemid 28441930)
19. Moreno JA, Izquierdo MC, Sanchez-Nino MD, Suárez-Alvarez B, Lopez-Larrea C, et al. (2011) The inflammatory cytokines TWEAK and TNFalpha reduce renal klotho expression through NFkappaB. J Am Soc Nephrol 22: 1315-25.
20. Sugiura H, Yoshida T, Tsuchiya K, Yoshida S, Shiohira S, et al. (2005) Klotho reduces apoptosis in experimental ischaemic acute renal failure. Nephrol Dial Transplant 20: 2636-45. (Pubitemid 41672261)
21. Koh N, Fujimori T, Nishiguchi S, Tamori A, Shiomi S, et al. (2001) Severely reduced production of klotho in human chronic renal failure kidney. Biochem Biophys Res Commun 280: 1015-20. (Pubitemid 32924441)
22. Ohyama Y, Kurabayashi M, Masuda H, Nakamura T, Aihara Y, et al. (1998) Molecular cloning of rat klotho cDNA: markedly decreased expression of klotho by acute inflammatory stress. Biochem Biophys Res Commun 251: 920-5. (Pubitemid 28512812)
23. Mitani H, Ishizaka N, Aizawa T, Ohno M, Usui S, et al. (2002) In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage. Hypertension 39: 838-43. (Pubitemid 34437536)
24. Narumiya H, Sasaki S, Kuwahara N, Irie H, Kusaba T, et al. (2004) HMG-CoA reductase inhibitors up-regulate anti-aging klotho mRNA via RhoA inactivation in IMCD3 cells. Cardiovasc Res 64: 331-6. (Pubitemid 39361695)
25. Saito K, Ishizaka N, Mitani H, Ohno M, Nagai R (2003) Iron chelation and a free radical scavenger suppress angiotensin II-induced downregulation of klotho, an anti-aging gene, in rat. FEBS Lett 551: 58-62. (Pubitemid 37281328)
26. Mitobe M, Yoshida T, Sugiura H, Shirota S, Tsuchiya K, et al. (2005) Oxidative stress decreases klotho expression in a mouse kidney cell line. Nephron Exp Nephrol 101: e67-74. (Pubitemid 41208903)
27. Wen M, Segerer S, Dantas M, Brown PA, Hudkins KL, et al. (2002) Renal injury in apolipoprotein E-deficient mice. Lab Invest 82: 999-1006.
28. Zhang SH, Reddick RL, Piedrahita JA, Maeda N (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258: 468-71.
29. Mas S, Touboul D, Brunelle A, Aragoncillo P, Egido J, et al. (2007) Lipid cartography of atherosclerotic plaque by cluster-TOF-SIMS imaging. Analyst 132: 24-6. (Pubitemid 44968846)
30. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, et al. (1995) Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 130: 393-405.
31. Catalan MP, Santamaria B, Reyero A, Ortiz A, Egido J, et al. (2005) 3,4-di-deoxyglucosone-3-ene promotes leukocyte apoptosis. Kidney Int 68: 1303-11. (Pubitemid 43246451)
32. Manea A, Tanase LI, Raicu M, Simionescu M (2010) Transcriptional regulation of NADPH oxidase isoforms, Nox1 and Nox4, by nuclear factor-kappaB in human aortic smooth muscle cells. Biochem Biophys Res Commun 396: 901-7.
33. Lopez-Franco O, Hernandez-Vargas P, Ortiz-Munoz G, Sanjuán G, Suzuki Y, et al. (2006) Parthenolide modulates the NF-kappaB-mediated inflammatory responses in experimental atherosclerosis. Arterioscler Thromb Vasc Biol 26: 1864-70. (Pubitemid 44305342)
34. Ha H, Lee HB (2005) Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney. Nephrology (Carlton) 10 Suppl: S7-10.
35. Jing Q, Xin SM, Cheng ZJ, Zhang WB, Zhang R, et al. (1999) Activation of p38 mitogen-activated protein kinase by oxidized LDL in vascular smooth muscle cells: mediation via pertussis toxin-sensitive G proteins and association with oxidized LDL-induced cytotoxicity. Circ Res 84: 831-9. (Pubitemid 29181490)
36. Kusuhara M, Chait A, Cader A, Berk BC (1997) Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages. Arterioscler Thromb Vasc Biol 17: 141-8. (Pubitemid 27057336)
37. Chai YC, Howe PH, DiCorleto PE, Chisolm GM (1996) Oxidized low density lipoprotein and lysophosphatidylcholine stimulated cell cycle entry in vascular smooth muscle cells. Evidence for release of fibroblast growth factor-2. J Biol Chem 271: 17791-7. (Pubitemid 26250754)
38. Chien MW, Chien CS, Hsiao LD, Lin CH, Yang CM (2003) OxLDL induces mitogen-activated protein kinase activation mediated via PI3-kinase/Akt in vascular smooth muscle cells. J Lipid Res 44: 1667-75. (Pubitemid 37185877)
39. Robbesyn F, Salvayre R, Negre-Salvayre A (2004) Dual role of oxidized LDL on the NF-kappaB signaling pathway. Free Radic Res 38: 541-51. (Pubitemid 38697088)
40. Lanske B, Razzaque MS (2007) Premature aging in klotho mutant mice: cause or consequence? Ageing Res Rev 6: 73-9. (Pubitemid 46661813)
41. Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimbürger O, et al. (2008) Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol 3: 505-21.
42. Stevens LA, Viswanathan G, Weiner DE (2010) Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance. Adv Chronic Kidney Dis 17: 293-301.
43. Yu J, Deng M, Zhao J, Huang L (2010) Decreased expression of klotho gene in uremic atherosclerosis in apolipoprotein E-deficient mice. Biochem Biophys Res Commun 391: 261-6.
44. Samuelsson O, Mulec H, Knight-Gibson C, Attman PO, Kron B, et al. (1997) Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant 12: 1908-15. (Pubitemid 27379464)
45. Nagai R, Saito Y, Ohyama Y, Aizawa H, Suga T, et al. (2000) Endothelial dysfunction in the klotho mouse and downregulation of klotho gene expression in various animal models of vascular and metabolic diseases. Cell Mol Life Sci 57: 738-46. (Pubitemid 30392032)
46. Haruna Y, Kashihara N, Satoh M, Tomita N, Namikoshi T, et al. (2007) Amelioration of progressive renal injury by genetic manipulation of Klotho gene. Proc Natl Acad Sci U S A 104: 2331-6. (Pubitemid 46391397)
47. Malle E, Woenckhaus C, Waeg G, Esterbauer H, Gröne EF, et al. (1997) Immunological evidence for hypochlorite-modified proteins in human kidney. Am J Pathol 150: 603-15. (Pubitemid 27073788)
48. Apostolov EO, Ray D, Savenka AV, Shah SV, Basnakian AG (2010) Chronic uremia stimulates LDL carbamylation and atherosclerosis. J Am Soc Nephrol 21: 1852-7.
49. Scheuer H, Gwinner W, Hohbach J, Gröne EF, Brandes RP, et al. (2000) Oxidant stress in hyperlipidemia-induced renal damage. Am J Physiol Renal Physiol 278: F63-74. (Pubitemid 30106126)
50. Lee HS (1999) Oxidized LDL, glomerular mesangial cells and collagen. Diabetes Res Clin Pract 45: 117-22.
51. Sanz AB, Sanchez-Nino MD, Ramos AM, Moreno JA, Santamaria B, et al. (2010) NF-kappaB in renal inflammation. J Am Soc Nephrol 21: 1254-62.
52. Kuwahara N, Sasaki S, Kobara M, Nakata T, Tatsumi T, et al. (2008) HMG-CoA reductase inhibition improves anti-aging klotho protein expression and arteriosclerosis in rats with chronic inhibition of nitric oxide synthesis. Int J Cardiol 123: 84-90. (Pubitemid 350250893)
53. Choi BH, Kim CG, Lim Y, Lee YH, Shin SY (2010) Transcriptional activation of the human Klotho gene by epidermal growth factor in HEK293 cells; role of Egr-1. Gene 450: 121-7.